API
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 7 sources · 18 days · First seen · Last updated

Hims & Hers Health legal and financial challenges

Overview

Telehealth provider Hims & Hers Health Inc. is navigating significant legal and financial pressures. The company is facing a lawsuit from the Federal Trade Commission, which is joined by Utah and Los Angeles County. The FTC alleges that the company shared sensitive consumer health data regarding conditions such as obesity and hair loss with advertising platforms like Meta and Snap. The agency also claims the company misled consumers regarding prescription charges and made subscription cancellations difficult. Hims & Hers has moved to dismiss the FTC lawsuit, arguing its privacy policy allows for sharing information with marketing partners.

In addition to regulatory scrutiny, the company faces a proposed securities class action in California from investors regarding its statements on personal health information protections.

Financially, the company reported a third-quarter loss of $33 million, or $0.14 per share, missing analyst expectations of a $0.06 per share profit. While quarterly revenue grew 49 percent to $890.4 million, it fell short of the $893.1 million projected by analysts. Gross margins also contracted from 73.8 percent to 57.2 percent, a decline attributed to the impact of branded GLP-1 weight loss offerings.

Following these results, the company lowered its annual revenue guidance to between $3.13 billion and $3.15 billion. Fourth-quarter revenue guidance was also revised downward to between $875 million and $895 million, which is significantly lower than market anticipation. The company noted a sequential decline of approximately 100,000 subscribers, bringing the total to 2.8 million, though international revenue surged by over 300 percent.

Entities

Northern District of California · Snap Inc. · FactSet · Hims & Hers Health Inc. · eucalyptus

Timeline

  1. [BUSINESS] 7 sources
    Hims & Hers Health reports Q3 loss and lowers revenue guidance

    Hims & Hers Health reported a Q3 loss of $33 million and lowered its full-year revenue guidance following disappointing quarterly results and shrinking gross margins.

  2. [BUSINESS] 2 sources
    Hims & Hers faces FTC lawsuit and investor litigation over privacy

    Hims & Hers is fighting an FTC lawsuit alleging it shared sensitive health data with advertisers and misled consumers regarding prescription charges and subscription cancellations.

Sources

antoniolinares.substack.com · cashcow.nl · ppc.land · pressreach.com · seekingalpha.com · stockstory.org · theasset.nl

This summary has been updated 1 time: see revision history